SHILPA BHAVSAR: Open Payments
NPI 1184928772 · ROUND ROCK, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$498 in 27 payments from 16 companies in 2025. Trend: 2023 $697 · 2024 $393 · 2025 $498
Food & beverage: $498
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 6 | $130 |
| AstraZeneca Pharmaceuticals LP | 3 | $56 |
| Abbott Laboratories | 3 | $47 |
| Novo Nordisk Inc | 2 | $47 |
| Kowa Pharmaceuticals America, Inc. | 2 | $33 |
| PFIZER INC. | 1 | $20 |
| Collegium Pharmaceutical, Inc. | 1 | $19 |
| Exact Sciences Corporation | 1 | $19 |
| Amgen Inc. | 1 | $18 |
| GlaxoSmithKline, LLC. | 1 | $18 |
Products named: VRAYLAR, FREESTYLE LIBRE 3, QULIPTA, ZORYVE, BREZTRI, Ozempic, Wegovy, UBRELVY.
Industry payments across TX — which companies pay providers there.
